Example 1 Therapeutic Area: ARDS

 https://www.athersys.com/investors/press-releases/press-release-details/2019/Athersys-Presents-Data-From-Its-Acute-Respiratory-Distress-Syndrome-Clinical-Trial-at-American-Thoracic-Society-International-Conference/default.aspx

Example 2 Therapeutic Area: STROKE

https://www.athersys.com/investors/press-releases/press-release-details/2015/Athersys-Announces-Results-From-Phase-2-Study-of-MultiStemR-Cell-Therapy-for-Treatment-of-Ischemic-Stroke/default.aspx

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30046-7/fulltext

Our Experience

Aeirtec has assisted companies for 20 years in progressing their candidates in phase 2 and 3 clinical studies and now with unique advanced multiple marker measurement technology.